Anti-tumorigenic agents can function through multiple pathways:
Inhibition of Cell Proliferation: By blocking the signals that promote cell division, these agents can prevent the rapid growth of cancer cells. Induction of Apoptosis: Some agents trigger programmed cell death in cancer cells, which helps in reducing the tumor mass. Angiogenesis Inhibition: Tumors require a blood supply to grow. Anti-angiogenic agents prevent the formation of new blood vessels, starving the tumor of nutrients. Immune System Modulation: Certain agents enhance the body's immune response against cancer cells, making it easier for the immune system to target and destroy them.
